Lisata Therapeutics, Inc. (LSTA)
Market Open
26 Oct, 08:00 PM
$
1. 06
+0.06
+6.4364%
$
8.97M Market Cap
- P/E Ratio
- Div Yield
61,650 Volume
-2.81 Eps
$ 1
Previous Close 
Want to track LSTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lisata Therapeutics, Inc. (LSTA) Statistics
Valuation metrics
Market Cap 8.97M
Enterprise value -1.47M
Trailing P/E (ttm) -0.61
Forward P/E -2.71
PEG ratio -0.02
Price/Sales (ttm) 89.74
Price/Book (mrq) 1.1
Enterprise Value/Revenue -14.69
Enterprise Value/EBITDA 0.09
Overview
Shares outstanding 9.11M
Float 7.19M
Shares short 70.25K
% Held by insiders 0.21%
% Held by institutions 0.11%
Average volume (10 days) 61.16K
Average volume (90 days) 297.82K
Price summary
52-Week low 0.96
52-Week high 5.07
Beta 1.11
50-Day moving average 1.37
200-Day moving average 2.46
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 15 Sep 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -146.21%
Operating margin -164.27%
Operational effectiveness
Return on assets -1.33%
Return on equity -1.14%
Income Statement
Revenue (ttm) 170K
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) 170K
EBITDA -17.2M
Net income to common (ttm) -16.35M
Diluted EPS (ttm) -1.61
Quarterly earnings growth (yoy) -0.9%
Balance Sheet
Total cash (mrq) 13.06M
Total cash per share (mrq) 1.15
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.69%
Book value per share (mrq) 0.88
Cash Flow
Cash flow statement -13.63M
Levered free cash flow (LFCF) -8.06M
2026 © Marketlog. All Rights Reserved.
